Answers are grounded in this paper and cite their sources.
The use of nano vesicular carriers has captured widespread attention from researchers across different disciplines. These nanovesicles are readily available, biocompatible, versatile, and stable, making them an appealing area of study. This review delves into an analysis of various trending nanovesicles such as aquasome, bilosome, cerosome, cubosome, enzymosome, ethosome, exosome, glycerosome, herbosome, hexosome, hyalurosome, invasome, liposome, marinosome, niosome, novasome, pharmacosome, phytosome, polymerosome, proniosome, sphingosome, spongosome, terpesome, ufasome, and virosome, and explores their applications in pharmaceuticals, cosmeceuticals, and other industries. Additionally, it discusses patents, clinical trials, advantages and disadvantages of different nanovesicles, shedding light on how different ingredients affect the physicochemical characteristics of these nanovesicles. The review also emphasizes the manifold implications of nanovesicles, particularly in the context of chemotherapy and specific drug targeting.
No takes yet. Share an insight, caveat, or question.
Jena et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: